Market Cap: $2.184T 0.31%
Volume(24h): $69.2158B -38.77%
  • Market Cap: $2.184T 0.31%
  • Volume(24h): $69.2158B -38.77%
  • Fear & Greed Index:
  • Market Cap: $2.184T 0.31%
Cryptos
Topics
Cryptospedia
News
CryptosTopics
Videos
Top News
Cryptos
Topics
Cryptospedia
News
CryptosTopics
Videos
bitcoin
bitcoin

$64566.812908 USD

0.23%

ethereum
ethereum

$1810.474514 USD

0.98%

tether
tether

$0.999022 USD

-0.03%

bnb
bnb

$590.524043 USD

0.06%

usd-coin
usd-coin

$0.999830 USD

0.01%

xrp
xrp

$0.951385 USD

-0.53%

solana
solana

$70.791567 USD

0.57%

tron
tron

$0.302344 USD

-1.59%

hyperliquid
hyperliquid

$66.043751 USD

0.99%

zcash
zcash

$884.280716 USD

-1.46%

dogecoin
dogecoin

$0.058467 USD

0.99%

monero
monero

$482.505734 USD

-1.49%

unus-sed-leo
unus-sed-leo

$9.190973 USD

0.78%

chainlink
chainlink

$9.081451 USD

-0.25%

cardano
cardano

$0.151877 USD

0.97%

Cryptocurrency News Articles

Quantum Biopharma Has Purchased an Additional $1 Million Worth of Bitcoin and Other Cryptocurrencies

May 20, 2025 at 04:03 am

The buys take Quantum's total cryptocurrency holdings to approximately $4.5 million, according to a May 19 press release.

Quantum Biopharma Has Purchased an Additional $1 Million Worth of Bitcoin and Other Cryptocurrencies

Canadian biotechnology company Quantum Biopharma has purchased an additional $1 million worth of Bitcoin and other cryptocurrencies.

The buys take Quantum’s total cryptocurrency holdings to approximately $4.5 million, according to a May 19 announcement. The biotech company plans to stake a portion of its crypto to generate revenue.

Quantum expects that holding a treasury of Bitcoin (BTC) and other crypto assets will “provide a return on investment for shareholders and […] provide some hedge against the Canadian dollar,” it said.

Shares of Quantum’s stock, QNTM, rose by approximately 25% following the announcement, according to data from Google Finance.

Related: Basel Medical shares down 15% on $1B Bitcoin buying plans

Quantum is one of several healthcare companies accumulating Bitcoin as corporate crypto treasuries become increasingly popular.

In March, NASDAQ-listed biopharmaceutical company Atai Life Sciences tipped plans to buy $5 million worth of Bitcoin.

In a March 20 X post, Atai’s founder, Christian Angermayer, said “Bitcoin should be a part of ANY corporate treasury – especially, in fact, in the biotech sector.”

Angermayer added in a blog post that Bitcoin can help the biotech hedge against inflation and stay solvent during the long periods before drug approvals.

On May 16, Singapore-based healthcare company Basel Medical Group announced plans to buy $1 billion worth of Bitcoin.

It said a Bitcoin treasury will support its plans to expand in Asia through acquisitions by giving Basel “one of the strongest balance sheets among Asia-focused healthcare providers.”

Unlike Quantum, however, Basel’s shares dropped significantly on the day of the announcement.

Collectively, corporate treasuries hold more than $83 billion in Bitcoin as of May 19, according to data from BitcoinTreasuries.NET.

Publicly traded companies are now the largest institutional Bitcoin holders after exchange-traded funds (ETFs), the data shows.

Bitcoin can “potentially be a valuable hedge against growing fiscal deficits, currency debasement, and geopolitical risks” for companies, asset manager Fidelity Digital Assets said in a 2024 report.

Original source:cointelegraph

Disclaimer:info@kdj.com

The information provided is not trading advice. kdj.com does not assume any responsibility for any investments made based on the information provided in this article. Cryptocurrencies are highly volatile and it is highly recommended that you invest with caution after thorough research!

If you believe that the content used on this website infringes your copyright, please contact us immediately (info@kdj.com) and we will delete it promptly.

Other articles published on Nov 17, 2026